Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion type Assertion NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_head.
- NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion description "[By combined HPV and cytology screening, a further 4% (95% CI: 3-5%) more CIN-3 lesions can be identified but at the expense of a 7% (95% CI: 5-9%) loss in specificity, in comparison with isolated HC2 screening.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_provenance.
- NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion evidence source_evidence_literature NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_provenance.
- NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion SIO_000772 16950021 NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_provenance.
- NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion wasDerivedFrom befree-20140225 NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_provenance.
- NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_assertion wasGeneratedBy ECO_0000203 NP390921.RAfAZG55nNDxavwJF9v-WDFCv4hbpiAXL16fTETLqg3fM130_provenance.